ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 128 filers reported holding ALLAKOS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $56,750 | -47.9% | 25,000 | 0.0% | 0.00% | -42.9% |
Q2 2023 | $109,000 | -25.3% | 25,000 | -23.8% | 0.01% | -22.2% |
Q1 2023 | $145,938 | -24.7% | 32,795 | +42.4% | 0.01% | -10.0% |
Q4 2022 | $193,913 | +26.7% | 23,030 | -7.9% | 0.01% | +100.0% |
Q3 2022 | $153,000 | +48.5% | 25,000 | -24.0% | 0.01% | +66.7% |
Q2 2022 | $103,000 | -46.4% | 32,908 | -2.1% | 0.00% | -50.0% |
Q1 2022 | $192,000 | -56.3% | 33,602 | -25.2% | 0.01% | -45.5% |
Q4 2021 | $439,000 | -27.2% | 44,895 | +687.6% | 0.01% | -26.7% |
Q3 2021 | $603,000 | – | 5,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |